Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: s402005 (Mark4321) Can PTSC survive DL without dilution? Not unless DL

In my opinion it all boils down to money, and who has more in the bank. Looks like TPL

has some of it's own patent litigation to worry about. That consumes more of their

money. If, as Wolf said, we can win against them in court and separate with our half of

the reverse eng. data, we can hire people, maybe even from the Lecrone staff to

continue rev. eng.

They may be looking for a job after this court action. We may also want to contact

Moore, via back channels, to see where he stands in this fight. I'm sure now he wishes

he was on our side in the Higgins debacle.

As a public company we may have a better chance than TPL of raising funds to continue

patent litigation, as long as it's not Schwartz (sp).

GLTA

Share
New Message
Please login to post a reply